TY - JOUR
T1 - Computer-guided normal-low versus normal-high potassium control after cardiac surgery
T2 - No impact on atrial fibrillation or atrial flutter
AU - Hoekstra, Miriam
AU - Hessels, Lara
AU - Rienstra, Michiel
AU - Yeh, Lu
AU - Oude Lansink, Annemieke
AU - Vogelzang, Mathijs
AU - van der Horst, Iwan C C
AU - van der Maaten, Joost M A A
AU - Mariani, Massimo A
AU - de Smet, Anne Marie G A
AU - Struys, Michel M R F
AU - Zijlstra, Felix
AU - Nijsten, Maarten W
N1 - Copyright © 2015 Elsevier Inc. All rights reserved.
PY - 2016/2
Y1 - 2016/2
N2 - Introduction This study was designed to determine the effect of 2 different potassium regulation strategies with different targets (within the reference range) on atrial fibrillation (AF) or atrial flutter (AFL) in a cohort of intensive care unit patients after cardiac surgery.Methods The GRIP-COMPASS study was a prospective double-blinded interventional study in 910 patients after cardiac surgery (coronary artery bypass grafting and/or valvular surgery). Patients were assigned to either the normal-low potassium target (nLP group, 4.0 mmol/L) or the normal-high potassium target (nHP group, 4.5 mmol/L) in alternating blocks of 50 patients. Potassium levels were regulated using a validated computer-assisted potassium replacement protocol (GRIP-II). The primary end point was the incidence of AF/AFL on a 12-lead electrocardiogram during the first postoperative week.Results Of the 910 patients, 447 were assigned to the nLP group; and 463, to the nHP group, with no baseline differences between the 2 groups. The mean daily administered dose of potassium was 30 +/- 23 mmol (nLP) versus 52 +/- 27 mmol (nHP) (P <.001), which resulted in mean intensive care unit potassium concentration of 4.22 +/- 0.36 mmol/L and 4.33 +/- 0.34 mmol/L, respectively (P <.001). The incidence of AF/AFL after cardiac surgery did not differ: 38% in the nLP group and 41% in the nHP group. Also in several subgroups (eg, patients not known with prior AF/AFL or with valve surgery), there were no differences.Conclusions There were no differences in incidence of AF/AFL with 2 potassium regulation strategies with different potassium targets and different amounts of potassium administered in patients after cardiac surgery.
AB - Introduction This study was designed to determine the effect of 2 different potassium regulation strategies with different targets (within the reference range) on atrial fibrillation (AF) or atrial flutter (AFL) in a cohort of intensive care unit patients after cardiac surgery.Methods The GRIP-COMPASS study was a prospective double-blinded interventional study in 910 patients after cardiac surgery (coronary artery bypass grafting and/or valvular surgery). Patients were assigned to either the normal-low potassium target (nLP group, 4.0 mmol/L) or the normal-high potassium target (nHP group, 4.5 mmol/L) in alternating blocks of 50 patients. Potassium levels were regulated using a validated computer-assisted potassium replacement protocol (GRIP-II). The primary end point was the incidence of AF/AFL on a 12-lead electrocardiogram during the first postoperative week.Results Of the 910 patients, 447 were assigned to the nLP group; and 463, to the nHP group, with no baseline differences between the 2 groups. The mean daily administered dose of potassium was 30 +/- 23 mmol (nLP) versus 52 +/- 27 mmol (nHP) (P <.001), which resulted in mean intensive care unit potassium concentration of 4.22 +/- 0.36 mmol/L and 4.33 +/- 0.34 mmol/L, respectively (P <.001). The incidence of AF/AFL after cardiac surgery did not differ: 38% in the nLP group and 41% in the nHP group. Also in several subgroups (eg, patients not known with prior AF/AFL or with valve surgery), there were no differences.Conclusions There were no differences in incidence of AF/AFL with 2 potassium regulation strategies with different potassium targets and different amounts of potassium administered in patients after cardiac surgery.
KW - CRITICALLY-ILL PATIENTS
KW - MORTALITY
KW - HYPERKALEMIA
KW - THERAPY
U2 - 10.1016/j.ahj.2015.10.020
DO - 10.1016/j.ahj.2015.10.020
M3 - Article
C2 - 26856215
SN - 0002-8703
VL - 172
SP - 45
EP - 52
JO - American Heart Journal
JF - American Heart Journal
ER -